163 related articles for article (PubMed ID: 10717335)
1. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.
García-Corbeira P; Dal-Ré R; Aguilar L; García-de-Lomas J
Vaccine; 2000 Apr; 18(21):2173-6. PubMed ID: 10717335
[TBL] [Abstract][Full Text] [Related]
2. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.
Cattaneo LA; Reed GW; Haase DH; Wills MJ; Edwards KM
J Infect Dis; 1996 May; 173(5):1256-9. PubMed ID: 8627081
[TBL] [Abstract][Full Text] [Related]
3. The seroepidemiology of B. pertussis infection in Catalonia, Spain.
Domínguez A; Vidal J; Plans P; Salleras L
Epidemiol Infect; 2001 Apr; 126(2):205-10. PubMed ID: 11349970
[TBL] [Abstract][Full Text] [Related]
4. Pertussis seroepidemiology in Taipei.
Chiu TF; Lee CY; Lee PI; Lu CY; Lin HC; Huang LM
J Formos Med Assoc; 2000 Mar; 99(3):224-8. PubMed ID: 10820955
[TBL] [Abstract][Full Text] [Related]
5. Distribution of pertussis antibodies among different age groups in Japan.
Konda T; Kamachi K; Iwaki M; Matsunaga Y
Vaccine; 2002 Mar; 20(13-14):1711-7. PubMed ID: 11906757
[TBL] [Abstract][Full Text] [Related]
6. Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.
Polyzou A; Pournaras S; Dafni U; Sofianou D; Christeli E; Patrinos S; Tsakris A
J Clin Lab Anal; 2004; 18(3):211-4. PubMed ID: 15103688
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of pertussis in China: need to improve vaccination strategies.
Xu Y; Wang L; Xu J; Wang X; Wei C; Luo P; Ma X; Hou Q; Wang J
Hum Vaccin Immunother; 2014; 10(1):192-8. PubMed ID: 24018405
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
9. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
[TBL] [Abstract][Full Text] [Related]
11. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
[TBL] [Abstract][Full Text] [Related]
12. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
13. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Cherry JD; Gornbein J; Heininger U; Stehr K
Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
15. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
[TBL] [Abstract][Full Text] [Related]
16. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
Zackrisson G; Taranger J; Trollfors B
J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
[TBL] [Abstract][Full Text] [Related]
17. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.
Aase A; Herstad TK; Jørgensen SB; Leegaard TM; Berbers G; Steinbakk M; Aaberge I
Vaccine; 2014 Oct; 32(45):5931-6. PubMed ID: 25218299
[TBL] [Abstract][Full Text] [Related]
18. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
19. [Humoral response to the injection of acellular Pertussis vaccine].
Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
[TBL] [Abstract][Full Text] [Related]
20. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
